Very-low-birth-weight infants, prophylactic micafungin or fluconazole

Indian Journal of Pharmacology

Volumn 42, Issue 6, 2010, Pages 421-

  Gonzalez Granado, Luis ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; MICAFUNGIN;

CANDIDIASIS; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HUMAN; INFANT; LETTER; PREMATURITY; VERY LOW BIRTH WEIGHT;

EID: 78149378662     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.71904     Document Type: Letter

References (4)

1. Grover ND. Echinocandins: A ray of hope in antifungal drug therapy. Indian J Pharmacol 2010;42:9-11.
2. Sohn HS, Lee TJ, Kim J, Kim D. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea. Clin Ther 2009;31:1105-15.
3. Kawada M, Fukuoka N, Kondo M, Okazaki K, Kusaka T, Kawada K, et al. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants. Pediatr Infect Dis J 2009;28:840-2.
4. Warn PA, Sharp A, Morrissey G, Denning DW. In vivo activity of micafungin in apersistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Chemother 2002;50:1071-4.